Evia Bio is a life sciences innovation company that develops non-DMSO cryopreservation solutions.
Evia Bio has raised $5.5M in total funding. The most recent round was Series A. The last funding was announced in September 2026.
Evia Bio's investors include Newchip Accelerator, Pleasant Bay Capital Partners, Walleye Tank.
Evia Bio is headquartered in Minneapolis, United States.
Evia Bio is a life sciences innovation company that develops non-DMSO cryopreservation solutions.
Evia Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Evia Bio — Funding & Investors." VCBacked, September 16, 2026, https://www.vcbacked.co/company/evia-bio. Accessed October 31, 2026.
VCBacked. (2026). Evia Bio — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/evia-bio
{{cite web |title=Evia Bio — Funding & Investors |url=https://www.vcbacked.co/company/evia-bio |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated